Skip to main content
Premium Trial:

Request an Annual Quote

Genospectra Raises $16.4M in Series C Financing

NEW YORK, Sept. 14 (GenomeWeb News) - Genospectra has raised $16.4 million in a Series C financing round, the company said today.

 

Fremont, Calif.-based Genospectra plans to use the funding to develop cell-based assays and a quantitative cell-based method for gene expression profiling.

 

Batelle Ventures led the financing round. New investors were Agilent Ventures, 5AM Ventures, Aravis Ventures, Allen, and private investors. They were joined by existing investors Alex Zaffaroni, Frazier Healthcare Ventures, HBM Bioventures, Novartis Bioventures, Bio*One Capital, Bay City Capital, and Affymetrix.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.